E
Enveric Biosciences Inc (ENVB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$1.44
-0.08 (-4.95%)
Market Cap: $6.78M
Last updated: Nov 17, 2026 at 11:03 AM ET
Enveric Biosciences Inc (ENVB) Valuation Multiples
Enveric Biosciences (ENVB) trades at 0.2x sales and 1.1x book value. Its P/B of 1.1x is above its 5-year median of 0.7x. Its forward P/E is 23.1x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 23.1x |
| Price to sales | 0.2x |
| Price to book | 1.1x |
| PEG | N/A |
| FCF yield | -141.5% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 1.1x | 0.7x | N/A |
Valuation History
Over the 5 of the 10 year ends shown that have a P/B, its P/B ranged from 0.2x in 2022 to 10.8x in 2016.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $3.63 | N/A | 0.9x |
| 2024 | $64.51 | N/A | N/A |
| 2023 | $233.98 | 3.1x | 1.0x |
| 2022 | $374.36 | N/A | 0.2x |
| 2021 | $8,369.16 | N/A | 1.2x |
| 2020 | $13,318.67 | N/A | N/A |
| 2019 | $20,337.97 | N/A | N/A |
| 2018 | $39,236.08 | N/A | N/A |
| 2017 | $697,430.40 | N/A | N/A |
| 2016 | $1,464,603.83 | N/A | 10.8x |
Frequently Asked Questions About ENVB
What is ENVB's forward P/E ratio?
Enveric Biosciences has a forward P/E ratio of 23.1x.
What is ENVB's price to sales ratio?
Enveric Biosciences has a price to sales ratio of 0.2x.
ENVB pages: Overview, Earnings, Financials, Valuation, Competitors